Phenex (Biotechnology) Overview

  • Founded
  • 2002
Founded
  • Status
  • Out of Business
  • Employees
  • 14
Employees
  • Latest Deal Type
  • Out of Business

Phenex (Biotechnology) General Information

Description

Provider of drug discovery and development services intended to translate novel scientific findings into therapies that change current cancer and liver disease therapeutic regimens. The company's services include developing therapies that function as a receptor for bile acids, prevents liver diseases and assist to cure chronic inflammation, enabling patients to avail safe and satisfying treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Waldhofer Strasse 104
  • 69123 Heidelberg
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phenex (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 03-Sep-2021 000.00 Completed Out of Business
6. Equity Crowdfunding 000.00 000.00 Completed Generating Revenue
5. Secondary Transaction - Private 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 21-Sep-2010 00.00 000.00 Completed Generating Revenue
3. Grant 02-Jul-2009 00.000 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 02-Oct-2008 $11.7M $16.8M 000.00 Completed Generating Revenue
1. Early Stage VC 11-Oct-2005 $5.08M $5.08M Completed Startup
To view Phenex (Biotechnology)’s complete valuation and funding history, request access »

Phenex (Biotechnology) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of drug discovery and development services intended to translate novel scientific findings into therapies that
Biotechnology
Heidelberg, Germany
14 As of 2020
000.00
00000000 00 000.00

0000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
Niel, Belgium
00 As of 0000
000.00
00000000000 000.00

0000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cill
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phenex (Biotechnology) Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
eTheRNA Immunotherapies Venture Capital-Backed Niel, Belgium 00 000.00 00000000000 000.00
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 00000 000000000
0000000 Venture Capital-Backed Farmington, CT 0 00.000 0000000000 00.000
00000000 Formerly VC-backed Sunnyvale, CA 0 00.000 00000000000 00.000
0000000 Venture Capital-Backed Hannover, Germany 00 00000 00000000000 00000
You’re viewing 5 of 26 competitors. Get the full list »

Phenex (Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial